Keith Boettiger, head of Abbott’s neuromodulation division, discusses the increasing adoption of digital technology to improve access to health care.
Healthcare providers should take steps now to ensure that the telehealth modalities they use are HIPAA compliant.
Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19.
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.
Melatonin and other melatonin receptor agonists have demonstrated efficacy in the treatment of circadian rhythm disorders in both pediatric and adult populations.
Research has revealed that the SARS-CoV-2 viral infection may have neurological manifestations, with critical implications for clinical practice.
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.
In an address during the American Urological Association’s 2020 Live Virtual Experience, Anthony S. Fauci, MD, a member of the White House Coronavirus Task Force, said the coronavirus pandemic is nowhere near over, but public health measures are making a big difference in reducing the number of cases and related deaths.
Accumulating evidence suggests that COVID-19 can lead to neurological complications.
Regardless of the challenges a smaller group might have, a risk assessment is a baseline for any HIPAA program. The cost of this assessment is considerably less than a HIPAA fine.
Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
The bidirectional relationship between migraine and sleep disorders are examined in this article.
The etiology and management of peripheral neuropathy in Parkinson disease is discussed.
Driven by the No Child Left Behind Act of 2001, school districts responded to pressures to increase school rankings and test scores by having more children tested for ADHD.
A diagnosis of amyotrophic lateral sclerosis can be overlooked by clinicians unfamiliar with the various signs of the disease.
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
The ENSG-WFN published a report that details current understanding of the neurologic impacts of COVID-19.
The management of painful diabetic peripheral neuropathy requires the use of effective agents that also may aid in improving sleep and mood.
A combination of clinical, imaging, and neuropsychological examinations may aid in MS disease progression prognostication.
Mitigating the spread of a virus as infectious as SARS-CoV-2, the virus which causes COVID-19, requires having ample and accurate diagnostic tests available. However, in the United States community transmission began to occur before adequate testing measures could be implemented.
Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.
Severe neuropsychiatric dysfunction, including psychosis and dementia, is associated with more advanced Parkinson disease.
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
The CMS interim regulations are aimed at improving access to telemedicine and remote monitoring services in an effort to circumvent unnecessary exposure to COVID-19.
Can mere light become a revolutionary new treatment for traumatic brain injury, posttraumatic stress disorder, depression, stroke, Parkinson disease, and Alzheimer disease?
The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide.
AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.
Death anxiety is common in patients with metastatic cancer, including those with metastatic non-small cell lung carcinoma.
A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.
How should clinicians combat coronavirus disease (COVID-19) in their practice settings?
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.
The COVID-19 epidemic has underscored potential gaps in mental health services during emergencies, while also testing the resilience of healthcare workers and medical systems.
According to a review published in The New England Journal of Medicine, evidence from preclinical studies and clinical trials on intermittent fasting reveals benefits for a number of health conditions, including obesity, diabetes mellitus, cardiovascular disease, cancers, and neurologic disorders.
There is an emerging view that sleep disorders are not merely symptoms of psychiatric conditions; instead there may be a complex, bidirectional relationship between psychiatric and sleep disorders.
In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.
A new guideline from AAN offers recommendations on the use of behavioral, nutraceutical, and complementary and alternative medicine (CAM) for improving sleep disorders in children with ASD.